Renal tubular epithelial cells (RTC) form a barrier between the host and ascending microbes in upper urinary tract infection. Previous studies have shown the ability of the kidney to produce defensins – antimicrobial peptides that play a pivotal role in unspecific host defense. To further clarify the role of renal epithelium for direct antibacterial activity we investigated the expression, regulation and production of antimicrobial peptides by cultured human RTC. Cell culture supernatants of RTC exert strong bactericidal activity against Escherichia coli and Klebsiella pneumoniae, two of the most important pathogens in urinary tract infections. The antimicrobial effect depends on salt concentration, a typical feature of human defensins. RT-PCR of RNA from cultured proximal and distal RTC showed constitutive expression of human β-defensin 1 (hbd-1) and human β-defensin 2 (hbd-2) whereas only hbd-1 expression could be detected in RNA preparation from renal biopsy material. Hbd-2 expression of RTC was induced by inflammatory processes as shown by semiquantitative competitive RT-PCR. Coincubation of the cultured cells with IL-1α or E. coli promote the strongest hbd-2 induction whereas TNF-α and LPS lead to a weaker or no (IL-6) hbd-2 induction. This is the first evidence that human RTC are able to produce antibacterial substances in a biologically relevant amount and that β-defensins are candidate proteins responsible for this effect.

Keywords:
Renal tubular cells, Antibacterial activity, Defensins
1.
Krüger S, Brandt E, Klinger M, Krüger S, Kreft B: Interleukin-8 secretion of cortical tubular cells is directed to the basolateral environment and is not enhanced by apical exposure to Escherichia coli. Infect Immun 2000;68:328–334.
2.
Leeker A, Kreft B, Sandmann J, Bates J, Wasenauer G, Müller H, Sack K, Kumar S: Tamm-Horsfall protein inhibits binding of S- and P-fimbriated Escherichia coli to human renal tubular cells. Exp Nephrol 1997;5:38–46.
3.
Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T: Human β-defensin: An antimicrobial peptide of urogenital tissues. J Clin Invest 1998;101:1633–1642.
4.
Zucht HD, Grabowsky J, Schrader M, Liebke C, Jürgens M, Schulz-Kappe P, Forssmann WG: Human β-defensin-1: A urinary peptide present in variant molecular forms and its putative functional implication. Eur J Med Res 1998;3:315–323.
5.
Schnapp D, Reid CJ, Harris A: Localization of expression of human β-defensin-1 in the pancreas and kidney. J Pathol 1998;186:99–103.
6.
Zhao C, Wang I, Lehrer RI: Widespread expression of β-defensin-1 in human secretory glands and epithelial cells. FEBS Lett 1996;396:319–322.
7.
Hiratsuka T, Nakazato M, Ihi T, Minematsu T, Chino N, Nakanishi T, Shimizu A, Kangawa K, Matsukura S: Structural analysis of human β-defensin-1 and its significance in urinary tract infection. Nephron 2000;85:34–40.
8.
Nitschke M, Wiehl S, Ganz T, Kreft B: Production of human β-defensins by renal proximal tubular cells (abstract). Kidney Blood Press Res 1999;22:270.
9.
Bensch KW, Raida M, Mägert HJ, Schulz-Knappe P, Forssmann WG: Hbd-1: A novel β-defensin from human plasma. FEBS Lett 1995;368:331–335.
10.
Harder J, Bartels J, Christophers E, Schröder JM: A peptide antibiotic from human skin. Nature 1997;387:861.
11.
Harder J, Bartels J, Christopers E, Schröder JM: Isolation and characterization of human β-defensin-3, a novel human-inducible peptide antibiotic. J Biol Chem 2001;276:5707–5713.
12.
Diamond G, Kaiser V, Rhodes J, Russel JP, Bevins CL: Transcriptional regulation of β-defensin gene expression in tracheal epithelial cells. Infect Immun 2000;8:113–119.
13.
Wada A, Mori N, Oishi K, Hojo H, Nakahara Y, Hamanaka Y, Nagashima M, Sekine I, Ogushi K, Niidome T, Nagatake T, Moss J, Hirayama T: Induction of human β-defensin-2 mRNA expression by Helicobacter pylori in human gastric cell line MKN45 cells on cag pathogenicity island. Biochem Biophys Res Commun 1999;263:770–774.
14.
Detrisac CJ, Sens MA, Garvin AJ, Spicer SS, Sens DA: Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int 1984;25:383–390.
15.
Baer PC, Nockher WA, Haase W, Scherberich JE: Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation. Kidney Int 1997;52:1321–1331.
16.
Schmouder RL, Strieter RM, Walz A, Kunkel SL: Epithelial-derived neutrophil-activating factor-78 production in human renal tubular epithelial cells and in renal allograft rejection. Transplantation 1995;58:118–124.
17.
Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway BA, Greenberg EP, Valore EV, Welsh MJ, Ganz T, Tack BF, McCray PB Jr: Production of β-defensins by human airway epithelia. Proc Natl Acad Sci USA 1998;95:14961–14966.
18.
Bals R, Wang ZX, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM: Human β-defensin-2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 1998;102:874–880.
19.
O`Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, Kagnoff MF: Expression and regulation of the human β-defensins hbd-1 and hbd-2 in intestinal epithelium. J Immunol 1999;163:6718–6724.
20.
Hiratsuka T, Nakazato M, Date Y, Ashitani J, Minematsu T, Chino N, Matsukura S: Identification of human β-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Biochem Biophys Res Commun 1998;249:943–947.
21.
Goldmann MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM: Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997;88:553–560.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.